KP
Zoetis Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Librela (bedinvetmab) | Canine Osteoarthritis Pain | Launched |
| Solensia (frunevetmab) | Feline Osteoarthritis Pain | Launched |
| Vetscan OptiCell | Companion Animal Hematology Diagnostics | Launched |
| mAb Pipeline Candidates | Atopic Dermatitis & Other Chronic Conditions (Dogs/Cats) | Development |
| Next-Gen Parasiticides | Parasite Prevention (Dogs/Cats) | Development/Launched |
| Basepaws Platform | Genetic & Wellness Screening (Cats) | Launched |
Leadership Team at Zoetis
WJ
Wetteny Joseph
Executive Vice President and Chief Financial Officer
RL
Roxanne Lagano
Executive Vice President and General Counsel
RP
Rob Polzer
Executive Vice President and President, U.S. Operations
MM
Mike McFarland, DVM
Executive Vice President and Chief Medical Officer